English français

Home > Veterinary tests > Scanelis PCR Tests > Cats > Leishmania

Quantitative detection of leishmania from the Leishmania donovani complex (L. infantum, L. donovani, L. chagasi).

Reasons for testing

- Diagnostics of feline leishmaniosis in all forms, even chronic forms.
- Status determination of a heathy animal
- Treatment monitoring

Test characteristics

- Real-time PCR
- Limit of detection
- Quantitative analysis (estimation)

Diagnostic samples

- Clinical suspicion – depending on clinical signs:
blood (EDTA) and/or cutaneous scraping and/or lymph node aspirate (lymph node hypertophy) and/or conjunctival cells. We advise you to collect several samples in order to perform a pool analysis.
- Healthy animal: bone marrow (EDTA) preferably
- Treatment monitoring: blood (EDTA) (blood is the earliest sample that become negative) then bone marrow if blood is negative

Result interpretation

- Negative result: absence of leishmania or quantity lower than the limit of detection. Leishmaniosis can be excluded if the analyzed samples were appropriate.
- Positive result: presence of leishmania, compatible with a feline leishmaniosis or a healthy carrier in an endemic area. In the canine population, the rate of asymptomatic carriers in blood was assessed with the Scanelis assay: 6%. If a cutaneous sample was collected, the detected load must be taken into account to interpret the result.

Special case of treatment monitoring : monitoring can be performed on blood which is the first to become negative (followed by bone marrow). After a negative result on blood, bone marrow is the most adapted sample for monitoring.
The animal can be regarded as negative after 2 negative results on bone marrow (the second must be performed 3 months later).

Do not hesitate to contact us for sample collecting advice or help in interpreting the results.